Shenzhen Hepalink Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 51.7% in First Half of 2022

Shenzhen Hepalink Pharmaceutical Group Co.,Ltd. (深圳市海普瑞药业集团股份有限公司) (002399.SZ) reported a net profit of 510.4 million yuan in the first half of 2022, up 51.7% year-on-year.

Meanwhile, the company posted 3.8 billion yuan in revenue, up 20.7% year-on-year.

At the end of the reporting period, it had 21.4 billion yuan in total assets and 9.2 billion yuan in total liabilities, with a liability-to-asset ratio of 43.1%.